AU2015901495A0 - Breast cancer risk assessment - Google Patents

Breast cancer risk assessment

Info

Publication number
AU2015901495A0
AU2015901495A0 AU2015901495A AU2015901495A AU2015901495A0 AU 2015901495 A0 AU2015901495 A0 AU 2015901495A0 AU 2015901495 A AU2015901495 A AU 2015901495A AU 2015901495 A AU2015901495 A AU 2015901495A AU 2015901495 A0 AU2015901495 A0 AU 2015901495A0
Authority
AU
Australia
Prior art keywords
breast cancer
risk assessment
cancer risk
assessment
breast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2015901495A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peter MacCallum Cancer Institute
Original Assignee
Peter MacCallum Cancer Institute
Filing date
Publication date
Application filed by Peter MacCallum Cancer Institute filed Critical Peter MacCallum Cancer Institute
Publication of AU2015901495A0 publication Critical patent/AU2015901495A0/en
Priority to PCT/AU2016/050297 priority Critical patent/WO2016172764A1/en
Priority to AU2016256598A priority patent/AU2016256598A1/en
Abandoned legal-status Critical Current

Links

AU2015901495A 2015-04-27 2015-04-27 Breast cancer risk assessment Abandoned AU2015901495A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/AU2016/050297 WO2016172764A1 (en) 2015-04-27 2016-04-27 Breast cancer risk assessment
AU2016256598A AU2016256598A1 (en) 2015-04-27 2016-04-27 Breast cancer risk assessment

Publications (1)

Publication Number Publication Date
AU2015901495A0 true AU2015901495A0 (en) 2015-05-14

Family

ID=

Similar Documents

Publication Publication Date Title
IL255217A0 (en) Cancer neoepitopes
IL251464A0 (en) Combination therapy for cancer
IL254705B (en) Combination therapy for cancer
EP3364949A4 (en) Cancer vaccines
EP3717644A4 (en) Detecting breast cancer
EP3280738A4 (en) Cancer neoepitopes
EP3151692A4 (en) Brassiere
HK1231381A1 (en) Combination therapy for cancer
HK1231561A1 (en) Cancer treatment
IL246761A0 (en) Combination therapy for cancer
GB201500584D0 (en) Cancer biomarkers
EP3391885A4 (en) Therapeutic agent for breast cancer
EP3256115A4 (en) Combination cancer therapy
EP3158885A4 (en) Brassiere
GB201519734D0 (en) Cancer therapy
GB201508480D0 (en) Cancer
HK1254687A1 (en) Combination therapy for cancer
GB2546773B (en) Cancer
GB201522433D0 (en) Cancer treatment
HRP20210383T8 (en) Combination therapy for cancer
AU2015901495A0 (en) Breast cancer risk assessment
AU2015905357A0 (en) Determining cancer aggressiveness
AU2015903329A0 (en) Novel cancer treatment
GB201511609D0 (en) Cancer therapy
GB201511120D0 (en) Cancer therapy